Valuation
- Market cap
- 2,143,000
- Revenue TTM
- $6,840,000
- Net income TTM
- $-25,130,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -367.40%
- Debt to equity
- 0.03
Trading
- Volume
- 223,100
- Avg volume
- 2,729,842
- Day's range
- $0.81 – $0.90
- Shares out
- 2,507,000
- Stochastic %K
- 19%
- Beta
- 2.39
- Analysts
- Strong Sell
- Price target
- $20.00
Company profile
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics...
Show more
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 978 878 9505
- Website
- https://www.invofertility.com
- Address
- 5582 Broadcast Court, Sarasota, United States
Latest news
No headlines yet.
